Tassilo Volz researcher
Volz, Tassilo
VIAF ID: 169412552 (Personal)
Permalink: http://viaf.org/viaf/169412552
Preferred Forms
- 100 0 _ ‡a Tassilo Volz ‡c researcher
- 100 1 _ ‡a Volz, Tassilo
- 100 1 _ ‡a Volz, Tassilo
4xx's: Alternate Name Forms (1)
5xx's: Related Names (3)
- 510 2 _ ‡a Hamburg, Univ
- 510 2 _ ‡a Universitätsklinikum Hamburg-Eppendorf ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Universitätsklinikum Hamburg-Eppendorf
Works
Title | Sources |
---|---|
Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism | |
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice. | |
Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection. | |
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. | |
Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice. | |
Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection | |
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo | |
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. | |
A humanized mouse model of liver fibrosis following expansion of transplanted hepatic stellate cells. | |
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. | |
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. | |
In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice | |
[Knowledge about HBV, prevention behaviour and treatment adherence of patients with chronic hepatitis B in a large referral centre in Germany] | |
Molekulare Mechanismen der chronischen Hepatitis-B (Hepadnaviridae) -Virus-Infektion vom Menschen zu experimentellen Mausmodellen für die Entwicklung effektiverer Therapiekonzepte | |
Multi-color RGB marking enables clonality assessment of liver tumors in a murine xenograft model. | |
Multiplexing clonality: combining RGB marking and genetic barcoding. | |
A Novel Orally Available Small Molecule That Inhibits Hepatitis B Virus Expression. | |
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B | |
Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. | |
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. | |
Primary human hepatocytes from metabolic-disordered children recreate highly differentiated liver-tissue-like spheroids on alginate scaffolds. | |
Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer. | |
Serum HBV pgRNA as a clinical marker for cccDNA activity. | |
A Slow Maturation Process Renders Hepatitis B Virus Infectious. | |
Small animal model systems for studying hepatitis B virus replication and pathogenesis. | |
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. | |
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice | |
T cell receptor grafting allows virological control of Hepatitis B virus infection |